 The Human Papilloma Virus (HPV) vaccine offers active immunisation against premalignant genital lesions (cervical,vulva and vagina), premalignant anal lesions, cervical cancers and anal cancers causally related to certain oncogenic HPV types.
The human papilloma virus HPV is the most common sexually transmitted infection. In many cases, infection does not cause any symptoms, but it can cause genital warts, and even lead to genital cancers, including cervical cancer (the second most common form of cancer in young women).
The use of condoms reduces your risk of contracting HPV. However, condoms are not 100% effective at preventing HPV infection as the virus can be present on the skin in the entire genital area.
The HPV vaccine consists of two or three doses, which are given by injection. The number of doses you require depends on your age.
The vaccination protocol for HPV is as follows:
Product: Guardasil
Age Group: 9 to and including 13 years of age
Primary Immunisation: 2-dose schedule (0.5 ml at 0 and 6 months)
Age Group: 14 years of age and older
Primary Immunisation: 3-dose schedule (0,2 and 6 months)
Please note that this treatment is only available for administration from on-site within the pharmacy.
|
